These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9433401)

  • 1. Prevalence of scleroderma spectrum disorders in the general population of Estonia.
    Valter I; Saretok S; Maricq HR
    Scand J Rheumatol; 1997; 26(6):419-25. PubMed ID: 9433401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Raynaud's phenomenon in 2 ethnic groups in the general population of Estonia.
    Valter I; Maricq HR
    J Rheumatol; 1998 Apr; 25(4):697-702. PubMed ID: 9558171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia.
    Valter I; Maricq HR
    Scand J Rheumatol; 1997; 26(2):117-24. PubMed ID: 9137327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of MS in south Estonia. Evidence of a new border of the Fennoscandian focus.
    Gross K; Kokk A; Kaasik AE
    Acta Neurol Scand; 1993 Oct; 88(4):241-6. PubMed ID: 8256565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-dependent diabetes mellitus in native Estonians and immigrants to Estonia.
    Podar T; Tuomilehto-Wolf E; Tuomilehto J; LaPorte RE; Adojaan B
    Am J Epidemiol; 1992 Jun; 135(11):1231-6. PubMed ID: 1385671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of scleroderma spectrum disorders in Slovenia.
    Sipek Dolničar A; Rotar Z; Tomsič M
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):8-11. PubMed ID: 23190708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postal survey on asthma, chronic bronchitis and respiratory symptoms among adult Estonians and non-Estonians (FinEsS-study).
    Jannus-Pruljan L; Meren M; Põlluste J; Loit HM; Kiviloog J; Baburin A; Lundbäck B
    Eur J Public Health; 2004 Jun; 14(2):114-9. PubMed ID: 15230493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of childhood type 1 diabetes for Russians in Estonia and Siberia.
    Podar T; Laporte RE; Tuomilehto J; Shubnikov E
    Int J Epidemiol; 1993 Apr; 22(2):262-7. PubMed ID: 8505182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon: prevalence in an Italian population sample.
    De Angelis R; Salaffi F; Grassi W
    Clin Rheumatol; 2006 Jul; 25(4):506-10. PubMed ID: 16292469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for coronary heart disease in 55- and 35-year-old men and women in Sweden and Estonia.
    Johansson J; Viigimaa M; Jensen-Urstad M; Krakau I; Hansson LO
    J Intern Med; 2002 Dec; 252(6):551-60. PubMed ID: 12472917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical correlation of anticentromere antibody in Thai patients.
    Pakunpanya K; Verasertniyom O; Vanichapuntu M; Pisitkun P; Totemchokchyakarn K; Nantiruj K; Janwityanujit S
    Clin Rheumatol; 2006 May; 25(3):325-8. PubMed ID: 16220222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting suicide among Russians in Estonia in comparison with Estonians: case-control study.
    Kolves K; Sisask M; Anion L; Samm A; Värnik A
    Croat Med J; 2006 Dec; 47(6):869-77. PubMed ID: 17171808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing ethnic differences in mortality in Estonia after the collapse of the Soviet Union.
    Leinsalu M; Vågerö D; Kunst AE
    J Epidemiol Community Health; 2004 Jul; 58(7):583-9. PubMed ID: 15194720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of motor neurone disease and multiple sclerosis is different in Estonians and Russians. Data from South Estonia.
    Gross-Paju K; Oöpik M; Lüüs S; Kalbe I; Kaasik AE
    Eur J Neurol; 1999 Mar; 6(2):187-93. PubMed ID: 10053231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [From Thibierge-Weissenbach syndrome (1910) to anti-centromere antibodies (1980). Clinical and biological features of scleroderma].
    Meyer O
    Ann Med Interne (Paris); 1999 Jan; 150(1):47-52. PubMed ID: 10093661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of scleroderma spectrum disorders in the general population of South Carolina.
    Maricq HR; Weinrich MC; Keil JE; Smith EA; Harper FE; Nussbaum AI; LeRoy EC; McGregor AR; Diat F; Rosal EJ
    Arthritis Rheum; 1989 Aug; 32(8):998-1006. PubMed ID: 2788424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREST Syndrome: Clinical Expression of the Disease.
    Arana-Guajardo A; Villarreal-Alarcón M
    J Clin Rheumatol; 2017 Aug; 23(5):285. PubMed ID: 28742726
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
    Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
    Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-centromere antibodies in patients with systemic lupus erythematosus.
    Respaldiza N; Wichmann I; Ocaña C; Garcia-Hernandez FJ; Castillo MJ; Magariño MI; Magariño R; Torres A; Sanchez-Roman J; Nuñez-Roldan A
    Scand J Rheumatol; 2006; 35(4):290-4. PubMed ID: 16882593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and natural history of Raynaud phenomenon: A long-term follow-up (14 years) of a random sample from the general population.
    Carpentier PH; Satger B; Poensin D; Maricq HR
    J Vasc Surg; 2006 Nov; 44(5):1023-8. PubMed ID: 17098538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.